Search Results - Mahran Shoukier
- Showing 1 - 4 results of 4
-
1
Industry’s role in HIV, hepatitis B, and hepatitis C exclusion in AML and MDS clinical trials by Tahsin Anwar, Sean Malhotra, Mohammad A. H. Mian, Tahiya Anwar, Vamsi Kota, Mahran Shoukier
Published in Hematology (2023-12-01)Get full text
Article -
2
A Phase I Study of the Non-Receptor Kinase Inhibitor Bosutinib in Combination with Pemetrexed in Patients with Selected Metastatic Solid Tumors by Nagla Abdel Karim, Asad Ullah, Hongkun Wang, Mahran Shoukier, Steven Pulliam, Ahmed Khaled, Nikhil Patel, John C. Morris
Published in Current Oncology (2022-12-01)Get full text
Article -
3
The effect of eltrombopag in managing thrombocytopenia associated with tyrosine kinase therapy in patients with chronic myeloid leukemia and myelofibrosis by Mahran Shoukier, Gautam Borthakur, Elias Jabbour, Farhad Ravandi, Guillermo Garcia-Manero, Tapan Kadia, Jairo Matthews, Lucia Masarova, Kiran Naqvi, Koji Sasaki, Srdan Verstovsek, Jorge Cortes
Published in Haematologica (2020-09-01)Get full text
Article -
4
Post-transplantation cyclophosphamide reduces the incidence of acute graft-versus-host disease in patients with acute myeloid leukemia/myelodysplastic syndromes who receive immune... by Maro Ohanian, Farhad Ravandi, Maria E Suarez-Almazor, Adi Diab, Noha Abdel-Wahab, Houssein Safa, Ala Abudayyeh, Marina Konopleva, Stephen Gruschkus, Chantal Saberian, May Daher, Richard Champlin, Kaysia Ludford, Gheath Al-Atrash, Guillermo Garcia-Manero, Naval Daver, Hind Rafei, Jacinth Joseph, Gabriela Rondon, Laura Whited, Faisal Fa'ak, Cristina Knape, Mahran Shoukier, Megan Marcotulli, Alison M Gulbis, Betul Oran, Uday R Popat, Rotesh Mehta, Amin M Alousi
Published in Journal for ImmunoTherapy of Cancer (2021-02-01)Get full text
Article
